Status:
COMPLETED
The Neurocognitive Sub-study of Encore1
Lead Sponsor:
Kirby Institute
Collaborating Sponsors:
The HIV Netherlands Australia Thailand Research Collaboration
Conditions:
HIV
Eligibility:
All Genders
16+ years
Phase:
PHASE3
Brief Summary
The purpose is to investigate whether HIV and HIV medication can affect certain areas of brain function. This study will look at possible changes in brain function including memory, concentration and ...
Eligibility Criteria
Inclusion
- All subjects entering into the main study protocol at participating centres will be eligible to enter this sub-study.
Exclusion
- Existing neurological brain disease
- Recent (\<6months ) head injury
- Current major depression or psychosis
- Current alcohol abuse
- Intended use of recreational drugs during study period
- Uncontrolled medical conditions deemed to potentially interfere with cognitive function (e.g. uncontrolled diabetes, pyrexial illness, uraemia etc)
Key Trial Info
Start Date :
January 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2013
Estimated Enrollment :
71 Patients enrolled
Trial Details
Trial ID
NCT01516060
Start Date
January 1 2012
End Date
March 1 2013
Last Update
September 19 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
HIVNAT Research Collaboration
Bangkok, Thailand